Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Walker

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Research|May 6, 2014
Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastomaAndrea Schuessler, Corey Smith, Leone Beagley, et al.
Molecular Oncology|July 15, 2014
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
The American Journal of Gastroenterology|May 18, 2011
Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UKDavid G Walker, Horace R T Williams, Stephen P Kane, et al.
The American Journal of Gastroenterology|June 4, 2009
Characterization of inflammatory bowel disease with urinary metabolic profilingHorace R T Williams, I Jane Cox, David G Walker, et al.
Neuro-Oncology|August 18, 2011
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1Bryan W Day, Brett W Stringer, Mark D Spanevello, et al.
Neurosurgery|May 10, 2019
Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent GliomasChirag G Patil, David G Walker, Dennis M Miller, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Research|May 6, 2014
Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastomaAndrea Schuessler, Corey Smith, Leone Beagley, et al.
Molecular Oncology|July 15, 2014
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
The American Journal of Gastroenterology|May 18, 2011
Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UKDavid G Walker, Horace R T Williams, Stephen P Kane, et al.
The American Journal of Gastroenterology|June 4, 2009
Characterization of inflammatory bowel disease with urinary metabolic profilingHorace R T Williams, I Jane Cox, David G Walker, et al.
Neuro-Oncology|August 18, 2011
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1Bryan W Day, Brett W Stringer, Mark D Spanevello, et al.
Neurosurgery|May 10, 2019
Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent GliomasChirag G Patil, David G Walker, Dennis M Miller, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Pageof 4